Literature DB >> 23542148

Xiao-Qing-Long-Tang (Sho-seiryu-to) inhibited cytopathic effect of human respiratory syncytial virus in cell lines of human respiratory tract.

Jung San Chang1, Chia Feng Yeh, Kuo Chih Wang, Den En Shieh, Ming Hong Yen, Lien Chai Chiang.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Xiao-Qing-Long-Tang (XQLT, TJ-19, Sho-seiryu-to, so-cheong-ryong-tang) has been used against acute airway diseases for thousands of year in ancient China. Most of the acute airway illnesses are caused by virus. However, without activity against influenza virus, XQLT has been questioned to manage respiratory tract viral infection. Nevertheless, XQLT might be active against airway viruses other than influenza. Human respiratory syncytial virus (HRSV) is one of the most common respiratory viral pathogens without effective management. However, it is unknown whether XQLT has anti-HRSV activity. AIM OF THE STUDY: We tested the hypothesis that XQLT can effectively minimize HRSV-induced plaque formation in respiratory tract mucosal cell lines.
MATERIALS AND METHODS: Anti-HRSV activity of a hot water extract of XQLT was examined by plaque reduction assay in both human upper (HEp-2) and low (A549) respiratory tract cell lines. Its effects on syncytial formation and viral fusion (F) protein were examined directly by microscopy and by western blot, respectively. Ability of XQLT to stimulate IFN-β was evaluated by enzyme-linked immunosorbent assay (ELISA).
RESULTS: Hot water extract of XQLT dose-dependently inhibited HRSV-induced plaque formation in both HEp-2 and A549 cells (P<0.0001), particularly when given before viral inoculation (p<0.0001). XQLT inhibited viral attachment (p<0.0001) and internalization (p<0.0001). 300μg/ml XQLT could decrease both the number and the size of HRSV-induced syncytium without clear effect on the production of viral F protein. XQLT could stimulate epithelial cells to secrete IFN-β before and after viral inoculation to counteract viral infection (p<0.0001).
CONCLUSIONS: XQLT is effective against HRSV infection on airway epithelia by preventing viral attachment, internalization, syncytial formation, and by stimulating interferon secretion.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23542148     DOI: 10.1016/j.jep.2013.03.044

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  10 in total

Review 1.  Recent advances in diagnosis, prevention, and treatment of human respiratory syncytial virus.

Authors:  Swapnil Subhash Bawage; Pooja Munnilal Tiwari; Shreekumar Pillai; Vida Dennis; Shree Ram Singh
Journal:  Adv Virol       Date:  2013-12-09

2.  So-Cheong-Ryong-Tang, a herbal medicine, modulates inflammatory cell infiltration and prevents airway remodeling via regulation of interleukin-17 and GM-CSF in allergic asthma in mice.

Authors:  Hyung-Woo Kim; Chi-Yeon Lim; Bu-Yeo Kim; Su-In Cho
Journal:  Pharmacogn Mag       Date:  2014-08       Impact factor: 1.085

3.  The modified Gingyo-san, a Chinese herbal medicine, has direct antibacterial effects against respiratory pathogens.

Authors:  Tetsuya Yamada; Takeaki Wajima; Hidemasa Nakaminami; Kaho Kobayashi; Hideaki Ikoshi; Norihisa Noguchi
Journal:  BMC Complement Altern Med       Date:  2016-11-14       Impact factor: 3.659

4.  Traditional Chinese medicine therapy decreases the pneumonia risk in patients with dementia.

Authors:  Shun-Ku Lin; Yueh-Ting Tsai; Pei-Chia Lo; Jung-Nien Lai
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

Review 5.  Unraveling the Molecular Mechanism of Traditional Chinese Medicine: Formulas Against Acute Airway Viral Infections as Examples.

Authors:  Yi Shin Eng; Chien Hsing Lee; Wei Chang Lee; Ching Chun Huang; Jung San Chang
Journal:  Molecules       Date:  2019-09-27       Impact factor: 4.411

Review 6.  Anti-COVID-19 drug screening: Frontier concepts and core technologies.

Authors:  Hua Luo; Mingming Zhao; Dechao Tan; Chang Liu; Lin Yang; Ling Qiu; Yan Gao; Hua Yu
Journal:  Chin Med       Date:  2020-10-28       Impact factor: 5.455

7.  Dynamic Microbial Shifts and Signatures of Long-Term Remission in Allergic Rhinitis After an Herbal Formula Treatment.

Authors:  Libing Zhu; Yuning Wu; Chenglong Lin; Lin Tang; Bin Yu; Wenrong Wan; Jingxiu Xuan; Yanling Du; Zhangran Chen; Wei Liang
Journal:  Front Immunol       Date:  2021-10-22       Impact factor: 7.561

8.  The Pretreatment of Xiaoqinglong Decoction Alleviates Inflammation and Oxidative Damage and Up-Regulates Angiotensin-Converting Enzyme 2 in Lipopolysaccharide-Induced Septic Acute Lung Injury Rats.

Authors:  Jing-Chao Su; Chen Cheng; Cai-Yun Wang; Yi Zhang; Ya-Ting He; Zi-Wei Guo; Xin-Yue Liu; Wen-Mei Liu; Yu-Jie Zhang; Shu-Wen Xu; Xin-Yue Zhang; Zi-Bing Liu; Xin-Fang Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-19       Impact factor: 2.650

Review 9.  Application of Traditional Chinese Medical Herbs in Prevention and Treatment of Respiratory Syncytial Virus.

Authors:  Li Li Lin; Jin Jun Shan; Tong Xie; Jian Ya Xu; Cun Si Shen; Liu Qing Di; Jia Bin Chen; Shou Chuan Wang
Journal:  Evid Based Complement Alternat Med       Date:  2016-09-04       Impact factor: 2.629

10.  Xiaoqinglong decoction (a traditional Chinese medicine) combined conventional treatment for acute exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis.

Authors:  Zhen Gao; Jing Jing; Yingying Liu
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.